An antisense transgenic strategy to inhibit the myelin oligodendrocyte glycoprotein synthesis

Molecular Brain Research

Volumn 43, Issue 1-2, 1996, Pages 333-337

  Jaquet, V ^a   Gow, A ^c   Tosic, M ^a   Suchanek, G ^b   Breitschopf, H ^b   Lassmann, H ^b   Lazzarini, R A ^c   Matthieu, J M ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense; Myelin; Myelin oligodendrocyte glycoprotein (MOG); Oligodendrocyte; RNA; Transgenic strategy

Indexed keywords

COMPLEMENTARY DNA; GLYCOPROTEIN; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; GENE FUSION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; MYELIN-ASSOCIATED GLYCOPROTEIN; OLIGONUCLEOTIDES, ANTISENSE; RATS;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 18244429457     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00219-7     Document Type: Article

References (19)

1. Amiguet, P., Gardinier, M.V., Zanetta, J.P. and Matthieu, J.-M., Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein, J. Neurochem., 58 (1992) 1676-1682.
2. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and Rutter, W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 187 (1979) 5294-5299.
3. Crooke, S.T., Progress towards oligonucleotide therapeutics: pharmacodynamic properties, FASEB J., 7 (1993) 533-539.
4. Erickson, R.P., The use of antisense approaches to study development, Dev. Genet., 14 (1993) 251-257.
5. Gardinier, M.V., Amiguet, P., Linington, C. and Matthieu, J.-M., Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily, J. Neurosci. Res., 33 (1992) 177-187.
6. Gow, A., Friedrich, V.L. and Lazzarini, R.A., Myelin basic protein gene contains separate enhancers for oligodendrocytes and Schwann cell expression, J. Cell Biol., 119 (1992) 605-616.
7. Gunn, C.A., Richards, M.K. and Linington, C., The immune response to myelin proteolipid in the Lewis rat: identification of the immunodominant B cell epitope, J. Neuroimmunol., 27 (1990) 155-162.
8. Katsuki, M., Sato, M., Kimura, M., Yokoyama, M., Kobayashi, K. and Nomura, T., Conversion of normal behavior to shiverer by myelin antisense cDNA in transgenic mice, Science, 241 (1988) 593-595.
9. Linington, C. and Lassmann, H., Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG), J. Neuroimmunol., 17 (1987) 61-69.
10. Matsumoto, K., Kakidani, H., Takahashi, A., Nakagata, N., Anzai, M., Matsuzaki, Y., Takahashi, Y., Miyata, K., Utsumi, K. and Iritani, A., Growth retardation in rats whose growth hormone gene expression was suppressed by antisense RNA transgene, Mol. Reprod. Dev., 36 (1993) 53-58.
11. Neckers, L. and Whitesell, L., Antisense technology: biological utility and practical considerations, Am. J. Physiol., 265 (1993) L1-L12.
12. Norton, W.T. and Poduslo, S.E., Myelination in rat brain: method of myelin isolation, J. Neurochem., 21 (1973) 749-757.
13. Piddlesden, S.J., Lassmann, H., Zimprich, F., Morgan, B.P. and Linington, C., The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement, Am. J. Pathol., 143 (1993) 555-564.
14. Pham-Dinh, D., Mattei, M.-G., Nussbaum, J.-L., Roussel, G., Pontarotti, P., Roeckel, N., Matther, I.H., Artzt, K., Fischer Lindahl, K. and Dautigny, A., Myelin/oligodendrocyte glycoprotein is a member of the subset of the immunoglobulin superfamily encoded within the major histocompatibility complex, Proc. Natl. Acad. Sci. USA, 90 (1993) 7990-7994.
15. Scolding, N.J., Frith, S., Linington, C., Morgan, B.P., Campbell, A.K. and Compston, D.A.S., Myelin oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation, J. Neuroimmunol., 22 (1989) 169-176.
16. Steinman, L., Connections between the immune system and the nervous system, Proc. Natl. Acad. Sci. USA, 90 (1993) 7912-7914.
17. Valera, A., Solanes, G., Fernandez-Alvarez, J., Pujol, A., Ferrer, J., Asins, G., Gomis, R. and Bosch, F., Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes, J. Biol. Chem., 269 (1994) 28543-28546.
18. Vass, K., Lassmann, H., Wekerle, H. and Wisniewski, H.-M., Distribution of Ia-antigen in the lesions of acute experimental allergic encephalomyelitis, Acta Neuropathol. (Berl.), 70 (1986) 149-160.
19. Xiao, B.-G., Linington, C. and Link, H., Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls, J. Neuroimmunol., 31 (1991) 91-96.